Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study
Top Cited Papers
Open Access
- 23 January 2025
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 226 (5) , 261-268
Abstract
Background: Nearly 3% of adults have attention-deficit and hyperactivity disorder (ADHD), although in the UK, most are undiagnosed. Adults with ADHD on average experience poorer educational and employment outcomes, worse physical and mental health and are more likely to die prematurely. No studies have yet used mortality data to examine the life expectancy deficit experienced by adults with diagnosed ADHD in the UK or worldwide.Aims: This study used the life-table method to calculate the life-expectancy deficit for people with diagnosed ADHD using data from UK primary care.Method: A matched cohort study using prospectively collected primary care data (792 general practices, 9 561 450 people contributing eligible person-time from 2000–2019). We identified 30 039 people aged 18+ with diagnosed ADHD, plus a comparison group of 300 390 participants matched (1:10) by age, sex and primary care practice. We used Poisson regression to estimate age-specific mortality rates, and life tables to estimate life expectancy for people aged 18+ with diagnosed ADHD.Results: Around 0.32% of adults in the cohort had an ADHD diagnosis, ~1 in 9 of all adults with ADHD. Diagnoses of common physical and mental health conditions were more common in adults with diagnosed ADHD than the comparison group. The apparent reduction in life expectancy for adults with diagnosed ADHD relative to the general population was 6.78 years (95% CI: 4.50 to 9.11) for males, and 8.64 years (95% CI: 6.55 to 10.91) for females.Conclusions: Adults with diagnosed ADHD are living shorter lives than they should. We believe that this is likely caused by modifiable risk factors and unmet support and treatment needs in terms of both ADHD and co-occurring mental and physical health conditions. This study included data from adults with diagnosed ADHD; the results may not generalise to the entire population of adults with ADHD, the vast majority of whom are undiagnosed.Keywords
Funding Information
- Public Health Research Programme (NIHR130914)
- Economic and Social Research Council (ES/S010467/1)
- Vivensa Foundation (RPGF1910\191)
This publication has 43 references indexed in Scilit:
- Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort studyWorld Psychiatry, 2022
- Higher Risk of Mortality for Individuals Diagnosed With Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder Demands a Public Health Prevention StrategyJAMA Pediatrics, 2022
- Mortality in Persons With Autism Spectrum Disorder or Attention-Deficit/Hyperactivity DisorderJAMA Pediatrics, 2022
- Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population‐based retrospective cohort studyInternational Journal of Methods in Psychiatric Research, 2021
- Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth CohortJAMA Network Open, 2021
- Exposure density sampling: Dynamic matching with respect to a time‐dependent exposureStatistics in Medicine, 2019
- The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrationsPharmacoepidemiology and Drug Safety, 2019
- Identifying periods of acceptable computer usage in primary care research databasesPharmacoepidemiology and Drug Safety, 2012
- Young Adult Gambling Behaviors and their Relationship with the Persistence of ADHDJournal of Gambling Studies, 2009
- The importance of defining periods of complete mortality reporting for research using automated data from primary carePharmacoepidemiology and Drug Safety, 2008